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Abstract
Chronic diseases are heavily taxing the American health system. The federal government has implemented
new laws, such as the Affordable Care Act (ACA), in order to increase American wellness at no additional cost
and to reduce the significant financial burden. Considering the enactment of ACA and cost cutting, it’s an
opportune time to explore new approaches to delivering high quality patient care before the start of a disease.
Preventative health wellness clinics can serve this purpose. However, preventative care clinics are not without
challenges. Modifying patients’ behaviors have proven to be difficult and no research literature exists to
provide an evidence-based approach which has a proven record in changing poor patient habits. However, if
focus is placed on patients who are at increased risk for developing a chronic illness and tests favorable for
behavior modification, the ideal preventative health clinic may set the stage for improved healthcare outcomes
and cost reduction.
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Abstract  
  
Chronic diseases are heavily taxing the American health system. The federal 
government has implemented new laws, such as the Affordable Care Act (ACA), in order to 
increase American wellness at no additional cost and to reduce the significant financial burden. 
Considering the enactment of ACA and cost cutting, it’s an opportune time to explore new 
approaches to delivering high quality patient care before the start of a disease. Preventative 
health wellness clinics can serve this purpose. However, preventative care clinics are not 
without challenges. Modifying patients’ behaviors have proven to be difficult and no research 
literature exists to provide an evidence-based approach which has a proven record in changing 
poor patient habits. However, if focus is placed on patients who are at increased risk for 
developing a chronic illness and tests favorable for behavior modification, the ideal preventative 
health clinic may set the stage for improved healthcare outcomes and cost reduction. 
I. Background  
a. Patient Protection and Affordable Care Act  
 
The institution of the Patient Protection and Affordable Care Act (PPACA) of 2010 or 
Affordable Care Act (ACA) has set the stage for a new paradigm in the delivery of healthcare in 
the United States (U.S.). Not only the law attempts to ensure every American has health 
insurance, it also strives to reduce the rising cost of healthcare. To address the rising cost, the 
ACA outline important preventive services for Americans. The goal is to avoid preventable 
illnesses and to improve health at no additional cost to the patient. Covered services include 
screening and counseling for alcohol abuse, blood pressure, diet, obesity, tobacco use, and 
cholesterol (DHHS, 2013). 
          
In addition to providing benefits to patients, ACA also provides perks for clinicians as 
well. Of particular interest are benefits relating to preventative care. The creation of new models 
of care coordination and increase health coverage, opens the door to exploring opportunities in 
preventative medicine and care. For example, in conjunction with ACA, the American Recovery 
and Reinvestment Act of 2009’s healthcare information technology objectives offer opportunities 
to receive patient information faster and exchange it electronically with other healthcare 
providers. Also, with an increase insured population and the desire to bulk up preventative care 
services, new business models can be entertained (i.e. preventative healthcare and wellness 
clinics). There is much to be gain from these laws in addition to the excitement of partaking in 
reducing the astronomical cost of America’s healthcare. 
b. Cost of Healthcare and Top Diseases/Conditions  
 
To take advantage of the PPACA preventative care benefits, it’s noteworthy to review 
the cost breakdown of salient diseases afflicting America’s population today. America’s national 
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health expenditure as a percent of gross domestic product (GDP) has continually increased 
from 16% in 2005 to a projected 19.8% in 2020 (CMS, 2011). Comparatively, other Organization 
for Economic Co-operation and Development (OECD) countries averaged 9.5% of GDP (2012). 
This has raised many concerns for policy makers as they try to curb the costs of healthcare. For 
example, chronic diseases comprise 75% of healthcare spending (CDC, 2011).  Most 
individuals are at the age of 65 and over, comprising 13% of the U.S. population. However, in 
2002, this age population consumed 36% of healthcare expenses (AHRQ, 2006). This prompts 
the need for better prevention and treatment practices for chronically ill patients. (Please see 
Appendix A for charts and graphs.) 
  
The top ten most expensive chronic illnesses, in order, are heart conditions, trauma-
related disorders, cancer, mental disorders, chronic obstructive pulmonary disease (COPD) 
including asthma, osteoarthritis, diabetes mellitus (DM), hypertension, back problems, and 
hyperlipidemia (AHRQ, 2010). Obesity related healthcare costs are closely linked to many of the 
top ten conditions (Finkelstein, Trogdon, Cohen, & Dietz, 2009). For the purposes of our 
preventative healthcare clinic, we will focus efforts on addressing the current top six chronic 
diseases/conditions affecting Americans. They are heart disease, stroke, mental disorders, 
chronic obstructive pulmonary disease (COPD) & asthma, diabetes, and obesity. These 
diseases are most amenable to lifestyle changes and prevention strategies.  
 
Heart disease and stroke are widespread conditions affecting many Americans and 
costing the U.S. health system billions of dollars each year. According to an AHRQ panel 
survey, heart conditions are America’s most expensive medical condition, totaling $107 billion 
per year (AHRQ, 2010). Heart disease is the leading cause of death for both men and women. 
The Centers for Disease Control and Prevention (CDC) reports 600,000 people die of heart 
disease every year (CDC, 2013). Similarly to heart disease, stroke also contributes its share of 
over burdening America’s healthcare. The CDC estimates $38.6 billion per year is spent on 
handling patients with this disease (CDC, 2013). Stroke is considered the 4th leading cause of 
American deaths, killing 130,000 per year (CDC, 2013). The disease is also the leading cause 
of disability among U.S. adults, and requires a heavy expense. 
  
Mental disorders also add a financial burden to America’s health system. In 2010, $73 
million was spent on treating mental disorders. However, for the purpose of the proposed ideal 
clinic, depression will be the primary focus. Depression has established correlations to other 
chronic diseases and is the most prevalent mental health illness amongst older adults (Welch, 
Czerwinski, Ghimire & Bertsimas, 2009). In 2009, $22.8 billion was spent on the treatment of 
depression and another $17 to $44 billion was spent because of lost workdays. In a given year, 
18.8 million adults will suffer from a depressive illness (CDC, 2011). Finally, depression is also 
the principal cause of the 30,000 suicides occurring each year. 
 
In 2010, $49.9 billion was spent on managing COPD patients. Of that, over 55% of the 
cost results from complications such as emergency room visits and hospitalizations. COPD 
affects 13.1 million US adults, but another 24 million have evidence of impaired lung function. 
COPD is largely preventable, as smoking is the primary risk factor (causing approximately 85-
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90% of COPD deaths). Lag times between tobacco exposure and disease development mean 
that the prevalence of COPD will continue to rise (American Lung Association, 2011). 
   
In 2007, $56 billion in total was spent on treating asthma. The disease affects 25.9 
million Americans, of which 13.2 million had an asthma attack in 2011. Asthma accounted for an 
estimated 14.2 million lost work days, and for 2.1 million emergency visits. Although the cause 
of asthma is not well understood, the ability to prevent exacerbations can result in huge cost 
savings (American Lung Association, 2012). 
 
Diabetes treatments cost Americans over $51 billion in 2010. DM is the seventh leading 
cause of death in the United States and it is the leading cause of kidney failure, lower limb 
amputations, heart disease and stroke. There are 25.8 million Americans (8.3% of the US 
population) that have diabetes (NIH, 2010). The mortality rate among people with diabetes is 
double the rate among non-diabetic people within the same age group (NIH, 2010).The 
estimated number of Americans who are at risk for diabetes is 79 million. However, only 11% 
are aware they are at risk for developing DM (Reinberg, 2013).  
 
The sixth disease the proposed clinic will address is obesity. According to data from the 
National Health and Nutrition Examination Survey, between 2009 and 2010, over 78 million U.S. 
adults and about 12.5 million U.S. children and adolescents were obese (Ogden et al, 2012). 
America’s Health report (2012) states obesity can result in four common high-cost health 
problems: Type 2 diabetes, coronary heart disease, stroke, hypertension, and obesity-related 
cancers. Obesity-related healthcare costs approximately $117 billion annually. More than one 
quarter of U.S. healthcare costs are related to physical inactivity, overweight, and obesity. 
Therefore, it is important to prevent the occurrence of obesity, to prevent further consequences, 
and to reduce the healthcare cost for preventable health problems. 
 
c. Description and Goals for Preventative Healthcare Clinic  
 
Primary care is key to prevention and treatment of the aforementioned top chronic 
illnesses but unfortunately, the primary care system is suffering. Phillips & Bazemore (2010) 
review the history and current situation of primary care in the United States. It has been stated 
that due to the lack of a primary care centered healthcare system, the U.S. is falling farther 
behind in population health metrics. Furthermore, there is a huge gap in the U.S. physician 
workforce for primary care. Most physicians enter into subspecialty residencies because of the 
desire to land higher paying jobs in urban area hospitals. Still, primary care represents the 
greatest platform for formal healthcare – totaling 57% of all patient visits. Despite the volume of 
care, it is estimated to be only 6-7% of total healthcare spending for Medicare beneficiaries. The 
proposed prevention-oriented clinic captures the opportunity to address primary care needs, 
improve patient outcomes, implement innovative prevention strategies, and provide an 
integrative patient-centered solution for patients. 
 
In recognition of the benefits of primary care, the increasing costs of healthcare and the 
shortage of primary care physicians, we suggest a prevention-oriented clinic. This clinic will 
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target its resources toward populations at highest risk for the six chronic illnesses; having high 
capability for changing their individual behaviors; and adhering to recommended prevention or 
treatment guidelines. In this paper, we discuss the current literature on risk assessment for the 
target diseases and theories on change behavior. We hope to incorporate our findings to create 
a resource allocation matrix that will serve as a clinical decision support tool to separate patients 
into cohorts for different levels of intervention.  
II. Literature Review  
a. Heart Disease and Stroke 
  
Heart disease and stroke risk factors are fairly well known because of organizations 
such as the American Heart Association (AHA) and federal programs stemming from the Joint 
Commission. Americans are educated about proven key risk factors contributing toward 
increasing susceptibility for developing heart disease and stroke (e.g., weight/body mass index 
(BMI), diet, exercise, blood pressure, alcohol consumption, smoking status, and cholesterol). 
Short risk assessment questionnaires are found throughout the Internet asking individuals to 
enter their most recent blood pressure, weight, and cholesterol readings. These tools typically 
free and calculate the risk scores based on the information entered by the end user. These tools 
do not serve as diagnosis, but rather educate patients about their risks. However, of particular 
interest is AHA’s website which includes a risk assessment tool as described in addition to their 
Get with the Guidelines tools for heart disease and stroke. These tools can be utilized for our 
preventative healthcare clinic. However, Gillespie and Lenz warns, although 70% of strokes and 
80% of heart disease are preventable, behavior change is the limiting factor (Gillespie & Lenz, 
2011). Therefore, our clinic will need to determine effective behavior modification tools and 
methodologies which could lead to effective change.  
b. Mental Illnesses and Depression 
 
Depression is one of the most prevalent of mental disorders and has strong risk factors 
for developing other chronic conditions and vice versa (Rubin, 2011). There are many screening 
tools that are easily accessible and available for general mental illness and depression, but no 
risk assessment tool for developing mental illness or depression is available. A meta-analysis 
conducted by Gilbody, Sheldon, & House (2008) suggests that at present early detection does 
not change primary care treatment or hospital treatment, possibly resulting in little to no change 
in patient outcomes (O’Connor, Whitlock, Beil, Bradley, & Gaynes, 2009). It may be that early 
treatment for mental illnesses and depression is not yet well developed, thus early detection has 
little benefit. Klein, Glenn, Kosty, Seeley, Rhode, & Lewinsohn (2013) found the predictors for 
depression for young adults were female gender, anxiety disorder before age 18, family history 
of mood disorder, sexual abuse during childhood, subthreshold depressive symptoms, and poor 
physical health. Their study acknowledged that a creation of a risk assessment tool is needed 
and would be of benefit to at-risk youth.  
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c. COPD and Asthma 
 
The current assessment for COPD is to get the patient history on tobacco smoking, 
other inhalation exposures (such as occupational dusts or chemicals, air pollution, and/or 
passive exposure to smoking), and familial tendency for COPD. Genetic testing for alpha-1 
antitripysin deficiency is rare but a significant risk factor for COPD (COPD CPM Workgroup, 
2013). The main assessment tools for COPD are to assess the stage of disease or the current 
patient condition. There are no specific tools developed to assess risk of developing COPD, so 
clinicians will have to be thorough in their patient history assessments (Ohar, Sadeghnejad, 
Meyers, Donohue & Bleecker, 2010).  
 
Despite the nearly 22 million people in America being affected by asthma, the etiology of 
the disease is not well known therefore current research cannot state assuredly what risk 
factors are the best predictors of disease (Subbarao, Mandhane, & Sears, 2009). It is 
understood that there is some gene-environment interaction that triggers the disease (Subbarao 
et al., 2009; Blumenthal, 2012). Some risk factors that have been associated with asthma are: 
prenatal maternal smoking, prenatal maternal antibiotic use, different types of infant and 
childhood wheezing, reduced airway/lung function in infancy, childhood antibiotic use, higher 
levels of immunoglobulin E at birth, infant and childhood exposure to tobacco smoke, particular 
occupational exposures, and smoking tobacco/marijuana (Subbarao et al., 2009). Asthma 
triggers and severity varies significantly (Subbarao et al., 2009). This has led researchers to 
develop assessment tools based on patient reported conditions and lung function tests. The two 
most prominently used risk assessment tools for asthma exacerbation are the Asthma Control 
Test (ACT) and the Asthma Control Questionnaire (ACQ) (Jia et al., 2012).   
d. Diabetes 
  
There are several screening methods for type 2 diabetes, such as oral glucose tolerance 
test (OGTT), hemoglobin A1c (HbA1C), fasting plasma glucose (FPG), family history of diabetes 
(FHD), and body mass index (BMI). Some of these tests are expensive and time consuming. 
Norberg et al (2006) examined the effective and more accurate screening methods, and found 
that the combination of HbA1c, FPG and BMI are effective in screening for individuals at risk of 
future clinical diagnosis of type 2 diabetes, while the OGTT or FHD is not necessary (Norberg et 
al, 2006). The Finnish Diabetes Risk Score (FINDRISC) is a well-established tool  and 
recommended for evaluation of the risk of Type 2 diabetes. The FINDRISC tool includes 
assessing the biomedical marker and the diabetes risk genetic marker. A study by Wang, 
Stancáková, Kuusisto, and Laakso shows that biochemical markers, but not genetic markers, 
improve the identification of previously undiagnosed type 2 diabetes (Wang et al., 2010). The 
Canadian Task Force on Preventive Healthcare conducted a study to identify a screening model 
that predicts high risk of future Type 2 diabetes and is useful in clinical practice. The study 
shows that management of other cardiovascular risk factors, such as dysglycemia, during 
diabetes risk screening is required. The examiner should consider obesity, physical inactivity, 
tobacco use, hypertension, and dyslipidemia in individuals with diabetes to give better prediction 
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about the likelihood of developing diabetes in the future (CMAJ, 2012). (See figure 11-14 in 
Appendix B.) 
 
e. Obesity 
 
Obesity has its own set of risk factors, but is also a major risk factor of other diseases 
such as diabetes, heart disease, stroke, hypertension and cancer (America’s Health, 2012). 
One projection model from the Robert Wood Johnson Foundation (Healthy Americans, 2012) 
suggests that if obesity rates continue on their track, the number of new cases of type 2 
diabetes, coronary heart disease and stroke could increase 10 times between 2010 and 2020–
and double again by 2030. Obesity could contribute to more than 6 million new cases of Type 2 
diabetes, 5 million new cases of coronary heart disease and stroke, and more than 400,000 new 
cases of cancer in the next two decades. However, if the average BMI is reduced by five 
percent, the number of cases would decrease dramatically and would save up to $81.7 billion 
(Healthy Americas, 2012). 
 
Some risk factors for obesity include genetics, inactivity, unhealthy diet, family lifestyle, 
smoking, certain medications, socioeconomic status, and other medical problems (Hebebrand & 
Hinney, 2009). Several studies recommend using the body mass index (BMI) as a reliable tool 
in screening overweight and obesity (NHLBI, 1998). (See figure 15 in Appendix B.) (Please see 
Table 1 in Appendix C for comparison of risk assessment tools.) 
 
III. Findings 
a. Preventative Healthcare Clinics  
 
 A Google search turned up limited number of Preventative Care clinics in existence 
today (i.e., Born Preventative Health Care Clinic, Samsum Clinic). The fascinating fact about 
this search is California appeared to be well represented.  For example, their Preventative 
Medical Center of Marin clinic provides some clues to the success of such clinics and the 
population needs. The center was founded by Dr. Elson M. Haas in 1984. His center blends 
traditional western and eastern therapies. It is evident his clinic is promoting wellness and 
attempting to prevent illness. Dr. Haas appears to be very successful, having authored several 
books and conducted speaking engagements throughout the country. The Marin Center 
provides services for managing chronic diseases/conditions such as asthma, hypertension, and 
diabetes (PMCM) in addition to wellness.  
 
It is unclear whether the center uses behavior and risk assessment tools as part of their 
patient care practices. The idea of utilizing behavior modification and risk assessment tools may 
set our clinic apart from the competition in addition to achieving greater results with getting 
patients to remain compliant and vigilant.  
 
b. Prevention Theory  
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According to Leavell and Clark (1965) the classifications of preventative strategies are: 
 
1)   Primary prevention are behaviors that maximize well-being and to avoid disease. The 
person does not have any diagnosable diseases is not in any high risk group. For 
example, A person exercises 3 times a week and meditates regularly to maintain health 
and manage stress. 
2)   Secondary prevention are behaviors that forestall the risk factor into developing into a 
serious disease. The person has a diagnosable risk factor, but not a definitive disease 
that will cause direct harm. For example, A person eats low cholesterol foods because 
currently has elevated cholesterol levels and takes statin medications. But this person 
would not immediately develop disease nor does the disease really affect their 
functioning. 
3)   Tertiary prevention is to prevent the progression of a disease. The person has a disease 
that affects theirs functioning and now are taking steps to slow progression, prevent 
complications, and death. For example, a person has developed cancer and now goes 
to all chemotherapy appointments on time, as scheduled, and follows all instructions to 
prevent infections.  
c. Behavior Modification and Tools  
 
Our literature review showed that there are some commonly used behavior change 
theories used by researchers and practitioners in designing intervention programs for some 
cases such as obesity, hypertension, DM type 2 (Gillespie & Lenz, 2011).  Behavior change 
theories help us understand individuals’ behaviors and design the intervention program. 
(Hildebrand, 2010). The most applied model is the Transtheoretical Model and Stages of 
Change. There are only a limited number of change behavior assessment tools that have been 
developed from these theories, as it is difficult to create questions specific for disease types that 
consistently prove valid, sensitive and specific.   
 
         However, a non-traditional tool to consider for heart and stroke patients is genetic 
susceptibility testing. Vassy, et al. (2013) discussed this tool for assessing patients’ tendencies 
to change behaviors if they are identified as high risk for developing heart disease and/or 
diabetes. Their study particularly honed into the young adult population (between 25 and 30 
years old). Although possibly promising, the study’s results were mixed and therefore, did not 
provide solid evidence that young adults may be motivated to change if they are identified as 
high risk. Despite this issue, the tool can be used to assess a younger generation for disease 
development for our proposed health clinic (Vassy et al., 2013). The best times to start 
developing good habits is to start early. If individuals are taught at a young age about the 
importance of diet, physical activity, and not smoking, this can contribute to lowering the total 
numbers of patients affected by heart disease/stroke.  (Please see Table 2 and Table 3 in 
Appendix C for list of behavior change theories and assessment tools.) 
 
IV. Recommendations  
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a. Overall Assessment 
 
Patient reported outcome (PRO) surveys have been used in research to obtain a quick 
but thorough understanding of the patient’s health condition. We reviewed several health PRO 
surveys and the most thoroughly developed, technologically advanced, and easiest to use for 
patients would be QOLIX which is developed by the John Ware Group.  
b. Heart Disease, Stroke, Diabetes, and Obesity 
 The recommended risk assessment for heart disease or stroke is the simple 
questionnaires provided by American Heart Association (AHA). DM and obesity also share 
similar risk factors and are themselves risk factors for heart disease and stroke therefore the 
questionnaire from the AHA is the recommended risk assessment tool. If the patient is between 
the ages of 25-30 year old, the genetic susceptibility testing tool may be reasonable considering 
these patients may be more willing to change if they discover he/she is ask risk for a deadly 
and/or debilitating disease. Primary prevention for these diseases involves diet and exercise 
(Reinberg, 2013). Secondary prevention are screening tools, and tertiary would be disease 
management guidelines provided by the AHA, and American Diabetes Association, which would 
also involve following a healthy diet, regular exercise, and medication regime (AACE, 2011). 
The recommended screening tools for DM are HbA1c blood tests. The recommended screening 
tools for both heart disease and stroke are to use the tools provided by the AHA’s Get with the 
Guidelines for HF/Stroke and AHA’s short heart disease risk calculator. AHA’s website has a of 
wealth information on heart disease and stroke. The knowledge should be leverage when caring 
for our clinic patients. There is no need to reinvent the wheel because their effectiveness have 
been proven and repeatedly used throughout the medical community. (See Figure 16, 17 in 
Appendix B.) 
c. Mental Illnesses and Depression 
 
 Overall the easiest to use, most studied, and cheapest depression screening tool is the 
Patient Health Questionnaire-2 (PHQ-2). It only has 2 items, free to use, easy to score, studied 
in primary care settings, and has proven to be sensitive, valid, and specific. The recommended 
screening tool for overall mental health is the M3 Checklist, it has also been studied in primary 
care settings and is free to use. There is not enough knowledge to create primary prevention 
strategies other than physical activity and healthy diet, for secondary prevention would be the 
use of these screening tools, and tertiary prevention also requires more research to determine 
how to prevent mental illness complications. (See Figure 18 in Appendix B.)  
d. COPD and Asthma  
Research in developing a scoring system to measure risk of developing COPD would be 
helpful to clinicians. Primary prevention would involve smoking cessation programs, as smoking 
is the primary risk factor for developing COPD. Screening those who smoke frequently with 
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stage testing could be used as a secondary prevention. Tertiary prevention would include close 
monitoring of symptoms with staging, and adherence to COPD disease management program. 
It is not suggested to screen patients for COPD that do not have a history of smoking or other 
risk factors as studies have shown a high false-positive result from spirometry testing in those 
over the age of 70 (US Preventive Services Task Force, 2008). Management of disease and 
exacerbations should follow GOLD recommendations as they are the most up to date, most 
supported by research, and represent the standard of care (GOLD, 2013). (See Figure 19 in 
Appendix B.) 
 
Current understanding of asthma does not identify the cause of the disease, 
associations of prenatal, infant, and childhood exposures to controllable behaviors are important 
considerations for primary prevention. Tertiary prevention would include risk assessment for 
asthma attacks. The NHLBI do not make specific recommendations on which asthma 
exacerbation risk assessment to use. All the questionnaires are easy to administer and the 
meta-analysis review for the ACT and ACQ reveal similar validity (Jia et al., 2012). The major 
difference would be that the ACQ was developed specifically for clinical use and therefore would 
be our recommendation as the risk assessment for tertiary prevention strategies. Recent studies 
have shown promise in the value of exhaled nitric oxide as predictor of loss of control of asthma 
but further investigation of feasibility and costs to implement in a primary care clinic before 
would be needed before recommendations for its use could be made (Ozier, Girodet, Bara, 
Tunon de Lara, Marthan, & Berger, 2011). (See Figure 20 in Appendix B.) 
V. Application to the Design of the Preventative Healthcare Clinic  
a. Recommended Behavior Modification Models and Tools  
 
University of Rhode Island Change Assessment Scale (URICA) was the only scale one 
that was not disease specific and considered the four stages of change as described by the 
transtheoretical model of change – precontemplation, contemplation, action, and maintenance. 
Many change behavior scales were tailored to substance use or addictions patients and not well 
studied for other health behavior changes. Therefore we recommend the URICA scale. Gillespie 
& Lenz (2011) suggest that the data from completed questionnaires should be used by the 
clinical staff to determine which behaviors to address first, help set patient-driven goals, 
determine what the patient is not interested in changing, and to help determine the participant’s 
stage of readiness to consistently participate in a behavior. (See Figure 21 in Appendix B.) 
 
         Although in our literature review we were unable to find any tools that assess social 
environment as predictors of change, many chronic illnesses are affected by socioeconomic 
factors. It would be prudent for clinicians to understand the socioeconomic barriers that prevent 
behavior change. 
b. Proposed Clinic High Level Definition Model  
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Level Sections Purpose or Function 
1 Greeter & 
Triage (at clinic 
entrance) 
Greet each patient, listen to his or her need, capture chief 
concern/complaint, and explain next step(s). For new patients, 
guide him/her to registration computer terminals. Established 
patients will be registered upon greeting the client. This is staffed 
by one unit secretary that can also flex to the family room if 
needed. (Estimated time less than 2 minutes.) 
2 Family Room 
(center of the 
clinic) 
This area is the patient registration, waiting area, and education 
area. New patients will complete full registration including contact, 
past and current medical information, reason for visit, and 
insurance at the computer terminals. The family room will have 6-
8 computers around a center table for registration and learning 
material. Established patients can quickly update their information 
if needed. This is staffed by one unit secretary that can also flex to 
the Greeter/Triage area if needed. (Estimated 5-10 minutes for 
established patients, 10-15 minutes for new patients.) 
3 Level 1 
Assessment 
(desk with 
privacy 
partitions) x 2 
For new clients only. A Licensed Practical Nurse (LPN) will give 
an overview of the clinic, the scope of practice, services, and 
costs. The patients will take the QOLIX online assessment and 
URICA. The LPN will review the results with the patients and 
evaluate the patient’s needs in relation to the results. The LPN will 
escort patient with all the results to a private exam room for the 
level 2 assessment. This is staffed by 2 LPNs. (Estimated 15 
minutes.) 
4 Level 2 
Assessment 
(private exam 
rooms) x 3 
For new clients only. The RN will complete (1) detailed disease 
specific assessments for staging and screening. Depending on the 
results from the QOLIX of what diseases clients are at risk for will 
determine the number of assessments that needs to be completed 
by the RN. The RN will also complete (2) basic physical exam 
such as vital signs, blood glucose (at risk diabetes), height, 
weight, calculate BMI, waist circumference, and other necessary 
measurements. RN will also (3) calculate care plan resources 
dependent upon client’s URICA score and risk score mapped onto 
the resource allocation matrix. If risk score not available, then use 
QOLIX score. This is staffed by 3 RNs. (Estimated 20-30 
minutes.) 
5 Care Planning 
Team 
For new clients, dependent upon the resource allocation matrix, 
the appropriate individualized care plan will be created and then 
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(same private 
exam rooms as 
Level 2 
Assessments) x 
3 
reviewed with the client by the care team. Dependent upon the 
results the care team may consist of a Nurse Practitioner(NP) 
and/or a Physiotherapist (PT) and/or a Registered Dietician (RD) 
and/or Social Worker (SW) and/or other alternative therapy 
practitioners. They may also refer patients to specialists for further 
disease management. The physician will work collaboratively with 
the three teams. With established patients, their role will be more 
supervisory as the care planning team will mainly be responsible 
for the client’s care management. The care team will also 
schedule the next appointment if needed. (Estimated 20-30 
minutes). This is staffed by 3 teams. 
For established patients, the care team member(s) will review 
client progress and current reported condition/concerns. Not every 
appointment will require the entire care team. The care plan will 
be adjusted as needed. (Estimated 10-20 minutes.) 
  The cycle time for new clients is estimated between 60-90 
minutes. The cycle time for return clients is estimated between 20-
30 minutes.  
 
Prevention requires holistic and integrated treatment for patients thus it is important to 
have easy access to the other necessary services for prevention. These include a fitness studio 
for activity promotion, pharmacy and related medical devices, foods that promote healthy eating, 
and areas for relaxation and mental wellness. Ideally these services would be operated in 
conjunction with the clinic to provide a “one-stop shop” center for clients. The diagram below 
would be ideal to provide easy access to related healthy behaviors other than medical 
assessments. (Please see Appendix D for clinic map and high level process map.) 
 
  
Clinic map in relation to other services 
Resource Allocation Matrix  
 
As stated in earlier, the goal of this paper is to devise a clinical decision support tool to aid 
clinicians in placing patients in cohorts to maximize effectiveness by determining how to allocate 
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limited resources. The resource allocation matrix below combines the URICA change behavior 
assessment and the QOLIX or specific disease risk score to determine who are the most at risk 
and who are most amenable to change. This cohort would require the focus of resources to 
prevent disease development and high healthcare costs for the future.  
 
 
Resource allocation matrix 
c. Rationale  
In the attempt to apply our knowledge from the literature review and class material into a 
prevention-oriented clinic, we needed to design a process and space that limited waste whilst 
still accomplishing the layers of assessments. The initial assessment of a new patient is a 
lengthy process, but we did try to limit the use of resources by assigning tasks to the least 
skilled person possible, leaving only the complex disease management to the case team. In our 
design the physician oversees many case teams so as not to rely too heavily on physicians, as 
there is a large primary care physician shortage. For return patients, the process is fairly 
straightforward with easy greet and registration process, then onto see the care team, with 
possible wait time at the family room with the educational material.  
VI. Conclusion  
   
 In conclusion, with the enactment of ACA, the landscape for preventative medicine is 
transforming. This is an ideal time to explore new approaches to care delivery and bring 
preventative care to the forefront. Current data shows that the majority of spending is directed to 
disease management, while there is less than 1 % going to preventive care. Chronic diseases 
consume a large portion of the healthcare budget, but this can be avoided by early detection 
and providing good preventive care for individuals at risk. The need to allocate resources wisely 
and ethically requires the assessment of two aspects when interviewing a new client, risk and 
compliance. Individuals who are at risk and show high level of changeability should receive the 
most resources. If a client has low level of readiness, education would be provided and the 
client would be reassessed. The overall aim is to improve the health of our community; we 
believe our clinic will set a new paradigm for preventative and wellness care clinics.       
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